Retrospective evaluation of the effects of diazepam in dogs with anxiety-related behavior problems.

J Am Vet Med Assoc

Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Published: November 2008

Objective: To characterize the effects of diazepam in dogs with behavior problems and to determine whether adverse effects were of sufficient concern to owners to prompt drug discontinuation.

Design: Cross-sectional study.

Sample Population: 37 dogs and their owners.

Procedures: Dogs for which diazepam had been prescribed by the behavior service of a veterinary teaching hospital from July 2005 through June 2007 were identified. Owners were interviewed via telephone to obtain data on dose and frequency of administration of diazepam, effectiveness, adverse effects, and, when applicable, reasons for discontinuing the drug.

Results: Diazepam was described as very (24% [9/37]) or somewhat (43% [16/37]) effective by most owners. At the time of the interview, 18 (49%) owners reported that they were still administering diazepam to their dogs. For the remainder, reasons for discontinuation included adverse effects (58% [11/19]) and lack of efficacy (53% [10/19]). Reported adverse effects included sedation, increased appetite, ataxia, agitation, increased activity, and aggression. Owners administering diazepam to ameliorate fear of thunderstorms (24% [9/37]) were more likely to view diazepam as effective than were owners of dogs that received it for separation anxiety (54% [20/37]). Owners of dogs that received > or = 0.8 mg of diazepam/kg (0.36 mg/lb) were more likely to report increased activity as an adverse effect than were owners of dogs that received < 0.8 mg/kg.

Conclusions And Clinical Relevance: Adverse effects of diazepam in dogs were commonly reported and often led to drug discontinuation. Owner education and follow-up is recommended to avoid treatment failure when prescribing diazepam for anxiety-related behavior problems in dogs.

Download full-text PDF

Source
http://dx.doi.org/10.2460/javma.233.9.1420DOI Listing

Publication Analysis

Top Keywords

adverse effects
20
diazepam dogs
16
effects diazepam
12
behavior problems
12
owners dogs
12
dogs received
12
diazepam
10
dogs
10
anxiety-related behavior
8
owners
8

Similar Publications

Background: Antibiomania is the manifestation of manic symptoms secondary to taking an antibiotic, which is a rare side effect. In these cases, the antibiotics most often incriminated are macrolides and quinolones, but to our knowledge, there are no published cases of antibiomania secondary to cotrimoxazole. Furthermore, we also provide an update of pharmacovigilance data concerning antibiomania through a search of the World Health Organization (WHO) database.

View Article and Find Full Text PDF

Background: The use of Complementary Medicine Products (CMPs) has been increasing worldwide, including among breastfeeding mothers. This study aims to investigate the reasons and associated factors of CMP use among breastfeeding mothers in Turkey, alongside their attitudes and experiences.

Methods: A descriptive cross-sectional study was conducted using a self-administered, anonymous online survey between 17 December 2023 and 17 March 2024.

View Article and Find Full Text PDF

Background: Previous guidelines have clearly stated that dance is safe and beneficial during pregnancy and for childbirth. However, due to the small sample size of individual studies and different interventions, there were inconsistencies about the effect of dance on maternal childbirth.

Methods: We included studies evaluating the effect of dance on women in labor.

View Article and Find Full Text PDF

Background: Paliperidone is a second-generation antipsychotic and the main active metabolite of risperidone, formulated to provide consistent therapeutic effects through an extended-release system, designed to provide consistent therapeutic effects through an extended-release formulation. While commonly used in clinical practice, switching from risperidone to paliperidone, particularly during valproate therapy, can pose challenges due to potential pharmacokinetic interactions that may increase the risk of extrapyramidal symptoms (EPS). Despite clinical observations suggesting these interactions, case reports documenting such adverse effects are scarce.

View Article and Find Full Text PDF

Continued Treatment with Nintedanib in Patients with Progressive Pulmonary Fibrosis: Data from INBUILD-ON.

Lung

January 2025

National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France.

Purpose: In the INBUILD trial in patients with progressive pulmonary fibrosis (PPF), nintedanib slowed the decline in forced vital capacity (FVC) versus placebo, with a safety profile characterised mainly by gastrointestinal events. INBUILD-ON, the open-label extension of INBUILD, assessed the safety of nintedanib during longer-term treatment. Data on FVC were collected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!